Is WELL Health Technologies (TSX:WELL) Undervalued Following Mixed Q2 Earnings?

Earnings event puts WELL Health Technologies under the microscope WELL Health Technologies (TSX:WELL) has stepped into the spotlight after reporting second quarter 2026 results that paired record quarterly revenue with a move from profit to loss. The company posted Q2 sales of CA$400.43 million compared with CA$356.67 million a year earlier, while net results shifted from income of CA$12.15 million to a net loss of CA$10.91 million. On a per share basis, basic and diluted loss from continuing...